Northwestern Mutual Wealth Management Co. Has $54.31 Million Holdings in Xylem Inc. $XYL

Northwestern Mutual Wealth Management Co. boosted its stake in Xylem Inc. (NYSE:XYLFree Report) by 2,309.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 431,824 shares of the industrial products company’s stock after purchasing an additional 413,904 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Xylem were worth $54,314,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Xylem by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 30,054,743 shares of the industrial products company’s stock valued at $4,092,855,000 after purchasing an additional 152,507 shares in the last quarter. State Street Corp raised its stake in Xylem by 1.2% in the third quarter. State Street Corp now owns 10,953,206 shares of the industrial products company’s stock valued at $1,615,598,000 after purchasing an additional 133,173 shares in the last quarter. Swedbank AB raised its stake in Xylem by 6.0% in the fourth quarter. Swedbank AB now owns 5,507,966 shares of the industrial products company’s stock valued at $750,075,000 after purchasing an additional 310,213 shares in the last quarter. Northern Trust Corp raised its stake in Xylem by 1.6% in the third quarter. Northern Trust Corp now owns 3,259,233 shares of the industrial products company’s stock valued at $480,737,000 after purchasing an additional 51,343 shares in the last quarter. Finally, Legal & General Group Plc raised its stake in Xylem by 12.2% in the third quarter. Legal & General Group Plc now owns 2,029,272 shares of the industrial products company’s stock valued at $299,318,000 after purchasing an additional 220,246 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on XYL shares. JPMorgan Chase & Co. dropped their price target on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research note on Thursday, April 16th. William Blair started coverage on Xylem in a research note on Monday, January 26th. They issued an “outperform” rating for the company. TD Cowen reiterated a “hold” rating on shares of Xylem in a research report on Monday, February 23rd. Mizuho set a $138.00 target price on Xylem in a research report on Wednesday, February 11th. Finally, UBS Group lifted their target price on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a research report on Wednesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Xylem has an average rating of “Moderate Buy” and an average price target of $152.77.

Get Our Latest Research Report on Xylem

Xylem Stock Performance

Xylem stock opened at $108.17 on Monday. Xylem Inc. has a 12-month low of $108.04 and a 12-month high of $154.27. The company has a quick ratio of 1.10, a current ratio of 1.46 and a debt-to-equity ratio of 0.13. The business’s 50-day moving average price is $120.40 and its two-hundred day moving average price is $132.54. The stock has a market cap of $25.71 billion, a PE ratio of 26.91, a P/E/G ratio of 1.54 and a beta of 1.08.

Xylem (NYSE:XYLGet Free Report) last released its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.09 by $0.03. Xylem had a return on equity of 11.26% and a net margin of 10.79%.The firm had revenue of $2.13 billion for the quarter, compared to analysts’ expectations of $2.11 billion. During the same quarter in the previous year, the business posted $1.03 earnings per share. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, analysts expect that Xylem Inc. will post 5.51 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Thursday, May 28th. Xylem’s payout ratio is 42.79%.

Xylem announced that its board has authorized a stock buyback program on Wednesday, February 25th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the industrial products company to repurchase up to 4.8% of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s management believes its stock is undervalued.

Insider Activity

In other news, Director Jerome A. Peribere purchased 1,210 shares of Xylem stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.32% of the company’s stock.

About Xylem

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Further Reading

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.